小兒學科

Medicine & Life Sciences

1. Taiwan 100%
2. Hyperoxia 91%
3. Lung 66%
4. Lung Injury 43%
5. Population 37%
6. Child 36%
7. Mothers 32%
8. Surface-Active Agents 29%
9. Air 27%
10. Kidney 27%
11. Pediatrics 27%
12. Cohort Studies 26%
13. Ventilator-Induced Lung Injury 25%
14. Bronchopulmonary Dysplasia 24%
15. Fibrosis 24%
16. Oligohydramnios 23%
17. Therapeutics 22%
18. Pregnancy 22%
19. Neuroblastoma 21%
20. Asthma 19%
21. Premature Infants 19%
22. Connective Tissue Growth Factor 18%
23. Mesenchymal Stem Cells 18%
24. Wounds and Injuries 18%
25. In Vitro Techniques 18%
26. Maternal Exposure 18%
27. Saline Solution 17%
28. Tigecycline 17%
29. Precursor Cell Lymphoblastic Leukemia-Lymphoma 17%
30. Collagen 17%
31. Pneumonia 17%
32. Nicotine 17%
33. Confidence Intervals 16%
34. Seizures 16%
35. Lipopolysaccharides 16%
36. Neoplasms 16%
37. Newborn Infant 15%
38. Gastroenteritis 15%
39. Stroke 15%
40. Genes 14%
41. Norovirus 14%
42. Apoptosis 13%
43. Retrospective Studies 13%
44. Inflammation 13%
45. Budesonide 13%
46. Paraquat 13%
47. Stem Cells 13%
48. Brain 13%
49. Proteins 12%
50. National Health Programs 12%
51. Very Low Birth Weight Infant 12%
52. Up-Regulation 11%
53. Serogroup 11%
54. Caliciviridae Infections 11%
55. Body Weight 11%
56. Pregnancy Outcome 11%
57. Meta-Analysis 11%
58. Pharmaceutical Preparations 11%
59. Hemophilia A 11%
60. Anti-Bacterial Agents 11%
61. Odds Ratio 10%
62. Infections 10%
63. Cytokines 10%
64. Databases 10%
65. Phenotype 10%
66. Malnutrition 10%
67. Gene Expression 10%
68. Serum 10%
69. Paraquat lung 10%
70. Oxidative Stress 10%
71. Ventilation 10%
72. Vascular Endothelial Growth Factor A 10%
73. Mutation 10%
74. Incidence 10%
75. Adrenal Cortex Hormones 9%
76. Renin-Angiotensin System 9%
77. Epoprostenol 9%
78. Fetal Growth Retardation 9%
79. Control Groups 9%
80. Klebsiella pneumoniae 9%
81. Sprague Dawley Rats 9%
82. thymic stromal lymphopoietin 9%
83. Ischemia 9%
84. Down-Regulation 9%
85. Systematic Reviews 9%
86. Bronchoalveolar Lavage Fluid 9%
87. Premature Birth 9%
88. Gestational Age 9%
89. CAP18 lipopolysaccharide-binding protein 9%
90. Parturition 9%
91. Epithelial-Mesenchymal Transition 9%
92. Gastrointestinal Diseases 9%
93. Methicillin-Resistant Staphylococcus aureus 8%
94. Acute Lung Injury 8%
95. Oxygen 8%
96. Vagus Nerve Stimulation 8%
97. Thioctic Acid 8%
98. Pulmonary Hypertension 8%
99. Gentamicins 8%
100. Marfan Syndrome 8%